Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Recommendation of Moderate Buy from Brokerages

Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) has been given a consensus rating of “Moderate Buy” by the fourteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average […]

Related Keywords

Birgit Girshick ,Shannonm Parisotto ,Robertw Baird ,Charles River Laboratories International ,Fulton Bank ,Securities Exchange Commission ,Manufacturing Solutions ,Charles River Laboratories International Price Performance ,Analyst Recommendations For Charles River Laboratories International ,Citigroup ,B Riley Wealth Advisors Inc ,Charles River Laboratories International Inc ,Research Models ,Morgan Stanley ,Charles River Laboratories International Company Profile ,Credit Suisse Group ,Get Rating ,Marketbeat Ratings ,Suisse Group ,Exchange Commission ,Ivy Capital Management ,Wealth Advisors ,Riley Wealth Advisors ,River Laboratories International ,Safety Assessment ,Charles River Laboratories International Daily ,Nyse Crl ,Crl ,Medical ,15986410 ,Ratings ,Consensus ,